Ascorbic Acid
In clinical developmentAlso known as Acidum ascorbicum, All Day C CR, Ascor, Ascorbinsäure+79 more
Acidum ascorbicum, All Day C CR, Ascor, Ascorbinsäure, Ascot, C-500, C-Time, Cecon, Cee-500, Cemill 1000, Cemill 500, Cevi-Bid, Concept OB, Dialyvite 800, Dialyvite 800 + Iron, Dialyvite 800 with Iron, Dialyvite 800 with Zinc, Fe-Tinic 150, Feogen, Fero-Grad-500, Ferocon, Ferotrin, Ferotrinsic, Ferralet 90, Ferraplus, Ferrex 150 Plus, Ferrogels Forte, Fetrin, Folitab, Folivane-F, Fumatinic, Halls Defense, Hemaspan, Hematogen, Hemax, Hemocyte-C, Icar C, Icar-C, Icar-C Plus, Infuvite, Infuvite Pediatric, Integra F, Irospan, Irospan Tablet, L-(+)-ascorbic acid, L-Ascorbic Acid, Lactocal, MVC-Fluoride, Macuvite with Lutein, Mega-C-Acid Plus, MoviPrep, Multi-Delyn, N Ice with Vitamin C, Natafort, Natelle, Nephrocaps, Nephrocaps QT, Ocuvite, Ocuvite Lutein, Poly-Vi-Sol, Poly-Vi-Sol with Iron, PreNexa, Prenatal Rx 1, PreserVision, PreserVision with Lutein, Rena-Vite, Special C, Sunkist Vitamin C, Tri-Vi-Sol, Tri-Vi-Sol with Iron, VITAMIN C, Vitabee with C, Vitafol-One, Vitamin C (Ascorbic Acid), Vitamin-C, Vitamina C, Vitelle Irospan, Vitron-C, Vitron-C Reformulated Jul 2016, acide ascorbique, acidum ascorbinicum, ascorbic acid (vit C), ácido ascórbico.
Recent clinical, regulatory, research and industry developments relating to this drug.
Reversing Glucose and Lipid-mediated Vascular Dysfunction (REGAL)
VItamin C in Thermal injuRY: The VICToRY Trial A Phase III Multi-center Randomized Trial
Vitamin C-Sources, Physiological Role, Kinetics, Deficiency, Use, Toxicity, and Determination.
Profile
Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.
Clinical trials
The current development programme across all trial phases — status mix, phase distribution and the late-stage studies shaping the evidence base.
Late-stage studies
Phase III+ trials still open or recently active — where late-stage evidence is being generated.
Recent completions
Trials that read out recently, adding to the completed evidence base.
Research activity
Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.
Major research themes8
Journals, researchers & institutions
- Nutrients2
- Archives of ophthalmology (Chicago, Ill. : 1960)1
- Comprehensive reviews in food science and food safety1
- Frontiers in immunology1
- International journal of cardiology1
- International journal of molecular sciences1
- Ali A1
- Allen BG1
- Araya J1
- Asenjo R1
- Azam M1
- Benedetti G1
- Berg DJ1
- Berrill M1
- Alma Mater Studiorum-University of Bologna1
- Centre for Human Psychopharmacology1
- Charles University1
- College of Public Health1
- Department of Clinical Biochemistry and Diagnostics1
- Department of Social and Clinical Pharmacy1
Related diseases
Regulator-approved indications and conditions co-mentioned with this drug across the research literature. Number shows shared papers.
Related drugs
Drugs sharing diseases, protein targets and literature with this one. Ranked by graph evidence (shared targets + diseases weighted above co-mentions).
Studied across 4 of the same disease areas as Ascorbic Acid in the shared literature.
Studied across 4 of the same disease areas as Ascorbic Acid in the shared literature.
Studied across 4 of the same disease areas as Ascorbic Acid in the shared literature.
Studied across 4 of the same disease areas as Ascorbic Acid in the shared literature.
Studied across 4 of the same disease areas as Ascorbic Acid in the shared literature.
Studied across 4 of the same disease areas as Ascorbic Acid in the shared literature.
Studied across 2 of the same disease areas as Ascorbic Acid in the shared literature.
Studied across the same disease area as Ascorbic Acid in the shared literature.
- RxNorm (U.S. National Library of Medicine) — drug identity
- ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
- Europe PMC — research literature
- ClinicalTrials.gov — clinical trials